IDDI is a highly reputed clinical research service provider. Since 1991 we offer biostatistics and eClinical services: trial design, centralized randomization (IWRS), data management, statistical analyses including DMC support, and medical writing in the field of clinical research. Our customers are biotech, pharmaceutical companies and Academic Groups. IDDI is headquartered in Belgium (Ottignies/Louvain-la-Neuve) with offices in the US (Raleigh, NC, USA). Thanks to its excellent quality data expertise, IDDI has helped secure 17 regulatory approvals. Since inception , IDDI has conducted over 900 trials. Our core area of expertise is oncology with substantial experience in ophthalmology. Our vision is to become a worldwide leader in supporting the development of new drugs and new biomarkers. Mission: IDDI’s mission is to optimize the clinical development of drugs, biologics, biomarkers and devices, using a unique combination of advanced biostatistics and innovative clinical data management technology. Company Values • Scientific brilliance, “no problem is too hard” • Unquestionable integrity and independence • Client minded, “Exceed client expectations” • Flexibility • Accountability • Team Spirit • Respect for individuals
51 to 200
TypeCompany - Private
Revenue$10 to $25 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded1991